Cargando…

Metabolic protein kinase signalling in neuroblastoma

BACKGROUND: Neuroblastoma is a paediatric malignancy of incredibly complex aetiology. Oncogenic protein kinase signalling in neuroblastoma has conventionally focussed on transduction through the well-characterised PI3K/Akt and MAPK pathways, in which the latter has been implicated in treatment resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smiles, William J., Catalano, Luca, Stefan, Victoria E., Weber, Daniela D., Kofler, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362370/ https://www.ncbi.nlm.nih.gov/pubmed/37414143 http://dx.doi.org/10.1016/j.molmet.2023.101771

Ejemplares similares

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
por: Catalano, Luca, et al.
Publicado: (2023)

From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2020)

Post-Translational Modifications of the Energy Guardian AMP-Activated Protein Kinase
por: Ovens, Ashley J., et al.
Publicado: (2021)

Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma
por: Feichtinger, Rene' G, et al.
Publicado: (2010)

Targeting Mitochondria in Melanoma
por: Aminzadeh-Gohari, Sepideh, et al.
Publicado: (2020)

Ketogenic diet in the treatment of cancer – Where do we stand?
por: Weber, Daniela D., et al.
Publicado: (2019)

Targeting anaplastic lymphoma kinase in neuroblastoma
por: Umapathy, Ganesh, et al.
Publicado: (2019)

WNT Signaling in Neuroblastoma
por: Becker, Juergen, et al.
Publicado: (2019)

Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts
por: Weber, Daniela D., et al.
Publicado: (2021)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling
por: Diao, Yumei, et al.
Publicado: (2014)

Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma †
por: Musumeci, Francesca, et al.
Publicado: (2021)

Protein kinase Cepsilon is important for migration of neuroblastoma cells
por: Stensman, Helena, et al.
Publicado: (2008)

Role of Energy Metabolism in the Progression of Neuroblastoma
por: Sakowicz-Burkiewicz, Monika, et al.
Publicado: (2021)

DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells
por: Dolman, M. Emmy M., et al.
Publicado: (2015)

Neuroblastoma Tyrosine Kinase Signaling Networks Involve FYN and LYN in Endosomes and Lipid Rafts
por: Palacios-Moreno, Juan, et al.
Publicado: (2015)

Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology
por: Rozen, Esteban Javier, et al.
Publicado: (2021)

Cell Signaling through Protein Kinase C Oxidation and Activation
por: Cosentino-Gomes, Daniela, et al.
Publicado: (2012)

Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
por: Guerra, Barbara, et al.
Publicado: (2020)

Therapeutic Targeting of the Anaplastic Lymphoma Kinase (ALK) in Neuroblastoma—A Comprehensive Update
por: Brenner, Annette K., et al.
Publicado: (2021)

Neuroblastoma
por: Pearson, D.
Publicado: (1977)

Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo
por: Li, Haoyu, et al.
Publicado: (2016)

WNT signaling, the development of the sympathoadrenal–paraganglionic system and neuroblastoma
por: Becker, Jürgen, et al.
Publicado: (2017)

Nuclear Factor-κB Activating Protein Plays an Oncogenic Role in Neuroblastoma Tumorigenesis and Recurrence Through the Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Pathway
por: Liu, Jun, et al.
Publicado: (2021)

Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity
por: Weber, Daniela D., et al.
Publicado: (2022)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

A protein kinase Cβ inhibitor attenuates multidrug resistance of neuroblastoma cells
por: Svensson, Karin, et al.
Publicado: (2003)

Editorial: Cell and Developmental Signalling in Neuroblastoma
por: Pulido, Rafael, et al.
Publicado: (2023)

Ketogenic diet in cancer therapy
por: Weber, Daniela D., et al.
Publicado: (2018)

The Roles of NDR Protein Kinases in Hippo Signalling
por: Hergovich, Alexander
Publicado: (2016)

Protein Kinases in the Photic Signaling of the Mammalian Circadian Clock
por: Alessandro, María S., et al.
Publicado: (2019)

Aurora Kinases as Targets in Drug-Resistant Neuroblastoma Cells
por: Michaelis, Martin, et al.
Publicado: (2014)

Metabolic Basis for Thyroid Hormone Liver Preconditioning: Upregulation of AMP-Activated Protein Kinase Signaling
por: Videla, Luis A., et al.
Publicado: (2012)

Gangliosides and Neuroblastomas
por: Schengrund, Cara-Lynne
Publicado: (2020)

TRIM proteins in neuroblastoma
por: Xu, Yonghu, et al.
Publicado: (2019)

Reprogramming plant specialized metabolism by manipulating protein kinases
por: Lyu, Ruiqing, et al.
Publicado: (2021)

Mitogen Activated Protein kinase signal transduction pathways in the prostate
por: Maroni, Paul D, et al.
Publicado: (2004)

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
por: Morscher, Raphael Johannes, et al.
Publicado: (2016)

MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
por: Pouliou, Marialena, et al.
Publicado: (2023)

Targeting lipid metabolism in cancer: neuroblastoma
por: Agostini, Massimiliano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1j0ed1b3sihi3f1lplf5729kdq